Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry
Status In-Process Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu dopisy
Grantová podpora
This study was sponsored by AstraZeneca GmbH, Hamburg, Germany.
PubMed
41439460
PubMed Central
PMC12766364
DOI
10.1002/ajh.70166
Knihovny.cz E-zdroje
- Klíčová slova
- hematological malignancy, neglected, opportunistic infection, real‐world data, respiratory syncytial virus,
- Publikační typ
- dopisy MeSH
[Image: see text]
AOU Policlinico Rodolico San Marco Catania Italy
ASST Grande Ospedale Metropolitano Niguarda Milan Italy
Azienda Ospedaliera Sant'Anna e San Sebastiano Caserta Italy
Azienda Sanitaria Universitaria del Friuli Centrale Udine Italy
CIBERINFEC Instituto de Salud Carlos 3 Madrid Spain
Clinic of Hematology University Clinical Center of Serbia Belgrade Serbia
Clinical Microbiology and Parasitology Department Hospital Universitario La Paz IdiPaz Madrid Spain
CRA from CRC Centre Hospitalier Victor DUPOUY Argenteuil France
Croatian Cooperative Group for Hematological Diseases Zagreb Croatia
Department of Haematology Blood Neoplasms and Bone Marrow Transplantation Wroclaw Poland
Department of Haematooncology Faculty of Medicine University of Ostrava Ostrava Czech Republic
Department of Haematooncology University Hospital Ostrava Ostrava Czech Republic
Department of Hematology and Oncology Comprehensive Cancer Center Innsbruck Innsbruck Austria
Department of Hematology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Hematology Research Unit Hospital Universitario de Burgos Burgos Spain
Department of Internal Medicine ADRZ Goes the Netherlands
Department of Mental Health and Public Medicine University of Campania Naples Italy
Department of Nephrology and Infectious Diseases AZ Sint Jan Brugge AV Brugge Belgium
Department of Oncohematology Comenius University and National Cancer Institute Bratislava Slovakia
Division of Hematology Department of Internal Medicine University of Debrecen Debrecen Hungary
Ematologia con Trapianto Ospedale Dimiccoli Barletta Barletta Italy
Facultad de Ciencias de la Salud Universidad Isabel I Burgos Spain
Faculty of Medicine Mansoura University Mansoura Egypt
Faculty of Medicine University of Belgrade Belgrade Serbia
Fundacion Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid Spain
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Gomel State Medical University Gomel Belarus
Head ICU and CRC Centre Hospitalier Victor DUPOUY Argenteuil France
Head of Clinic of Hematology Clinical Center of Novi Sad Novi Sad Serbia
Hematology and Bone Marrow Transplantation IRCCS San Raffaele Scientific Institute Milan Italy
Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy
Hematology and Stem Cell Transplant Unit Lecce Italy
Hematology and Stem Cell Transplantation Unit AOUC Policlinico Bari Italy
Hematology Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy
Hematology Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Hematology Unit ASST Spedali Civili Brescia Italy
Hematology Unit Center for Translational Medicine Azienda USL Toscana NordOvest Livorno Italy
Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
Hematology Università Cattolica del Sacro Cuore Rome Italy
Hospital Clinic Barcelona Spain
Hospital Morales Meseguer Murcia Spain
Hospital Nuestra Señora de Sonsoles Ávila Spain
Hospital Rey Juan Carlos Móstoles Spain
Hospital Universitario Príncipe de Asturias Alcalá de Henares Spain
Hospital University of Parma Hematology and Bone Marrow Unit Parma Italy
IRCCS AOU San Martino Genova Italy
Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' IRST Meldola Italy
King Faisal Specialist Hospital Jeddah Saudi Arabia
Laikon Hospital Medical School National and Kapodistrian University of Athens Athens Greece
McGill University Health Centre Montreal Canada
Medical University Wroclaw Poland
Medizinische Klinik 2 Klinikum rechts der Isar TU München Munich Germany
North Western State Medical University Named After Iliá Ilich Méchnikov Saint Petersburg Russia
Northumbria Healthcare Newcastle UK
Ospedale Policlinico San Martino Genoa Italy
School of Medicine University of Zagreb Zagreb Croatia
Stem Cell Transplant Center AOU Citta' della Salute e della Scienza Turin Italy
Universitätsklinikum Hamburg Eppendorf Hamburg Germany
University Clinic of Hematology Skopje Republic of North Macedonia
University Hospital Hradec Králové Hradec Králové Czech Republic
University Medical Center Groningen Groningen the Netherlands
Zobrazit více v PubMed
Shi T., McAllister D. A., O'Brien K. L., et al., “Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections due to Respiratory Syncytial Virus in Young Children in 2015: A Systematic Review and Modelling Study,” Lancet 390, no. 10098 (2017): 946–958. PubMed PMC
Herrmann S., Graefe S., Christopeit M., et al., “Respiratory Syncytial Virus Infection in Patients With Haematological Diseases: A Retrospective Multicentre Study,” Infection 53 (2025): 1341–1350. PubMed PMC
Khawaja F. and Chemaly R. F., “Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies,” Haematologica 104, no. 7 (2019): 1322–1331. PubMed PMC
Salmanton‐Garcia J., Marchesi F., Navratil M., et al., “Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023‐2024: EPICOVIDEHA‐EPIFLUEHA Report,” American Journal of Hematology 100, no. 3 (2025): 358–374. PubMed PMC
Salmanton‐Garcia J., Marchesi F., Itri F., et al., “Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients,” Hema 7, no. 11 (2023): e970. PubMed PMC
Infante M. S., Salmanton‐Garcia J., Fernandez‐Cruz A., et al., “B‐Cell Malignancies Treated With Targeted Drugs and SARS‐CoV‐2 Infection: A European Hematology Association Survey (EPICOVIDEHA),” Frontiers in Oncology 12 (2022): 992137. PubMed PMC
Ruiz‐Camps I. and Aguilar‐Company J., “Risk of Infection Associated With Targeted Therapies for Solid Organ and Hematological Malignancies,” Therapeutic Advances in Infectious Disease 8 (2021). PubMed PMC
Prasad N., Walker T. A., Waite B., et al., “Respiratory Syncytial Virus‐Associated Hospitalizations Among Adults With Chronic Medical Conditions,” Clinical Infectious Diseases 73, no. 1 (2021): e158–e163. PubMed
Manna S., Baindara P., and Mandal S. M., “Molecular Pathogenesis of Secondary Bacterial Infection Associated to Viral Infections Including SARS‐CoV‐2,” Journal of Infection and Public Health 13, no. 10 (2020): 1397–1404. PubMed PMC
Addo M., Cornely O., Denkinger M., et al., “RSV Vaccination Strategies for High‐Risk Patients 2023: A Collaborative Position Paper by Leading German Medical Societies and Organizations,” Infection 52, no. 1 (2024): 285–288. PubMed PMC